Royal Bank of Canada’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$292K Buy
100,897
+100,843
+186,746% +$292K ﹤0.01% 4546
2025
Q1
$0 Sell
54
-932
-95% ﹤0.01% 6560
2024
Q4
$3K Sell
986
-6,254
-86% -$19K ﹤0.01% 6155
2024
Q3
$47K Buy
7,240
+3,273
+83% +$21.2K ﹤0.01% 5265
2024
Q2
$29K Buy
3,967
+3,373
+568% +$24.7K ﹤0.01% 5518
2024
Q1
$4K Sell
594
-8,207
-93% -$55.3K ﹤0.01% 6059
2023
Q4
$40K Buy
8,801
+1,923
+28% +$8.74K ﹤0.01% 5548
2023
Q3
$27K Buy
6,878
+4,203
+157% +$16.5K ﹤0.01% 5586
2023
Q2
$8K Buy
+2,675
New +$8K ﹤0.01% 6086
2022
Q4
Sell
-42
Closed 6967
2022
Q3
$0 Buy
+42
New ﹤0.01% 7120
2021
Q2
Sell
-91
Closed -$1K 7013
2021
Q1
$1K Sell
91
-17
-16% -$187 ﹤0.01% 6804
2020
Q4
$2K Sell
108
-20
-16% -$370 ﹤0.01% 6304
2020
Q3
$2K Sell
128
-51
-28% -$797 ﹤0.01% 5827
2020
Q2
$2K Buy
179
+3
+2% +$34 ﹤0.01% 5809
2020
Q1
$1K Buy
176
+26
+17% +$148 ﹤0.01% 5949
2019
Q4
$2K Buy
150
+59
+65% +$787 ﹤0.01% 5949
2019
Q3
$1K Buy
91
+58
+176% +$637 ﹤0.01% 5794
2019
Q2
$0 Sell
33
-8
-20% ﹤0.01% 5945
2019
Q1
$1K Buy
41
+8
+24% +$195 ﹤0.01% 5625
2018
Q4
$2K Sell
33
-224
-87% -$13.6K ﹤0.01% 5548
2018
Q3
$36K Buy
257
+32
+14% +$4.48K ﹤0.01% 4790
2018
Q2
$28K Sell
225
-3,320
-94% -$413K ﹤0.01% 4819
2018
Q1
$317K Sell
3,545
-13
-0.4% -$1.16K ﹤0.01% 3442
2017
Q4
$197K Buy
3,558
+1
+0% +$55 ﹤0.01% 3729
2017
Q3
$150K Buy
3,557
+6
+0.2% +$253 ﹤0.01% 4020
2017
Q2
$149K Sell
3,551
-75
-2% -$3.15K ﹤0.01% 3844
2017
Q1
$202K Sell
3,626
-68
-2% -$3.79K ﹤0.01% 3711
2016
Q4
$141K Buy
3,694
+161
+5% +$6.15K ﹤0.01% 3962
2016
Q3
$140K Sell
3,533
-183
-5% -$7.25K ﹤0.01% 3925
2016
Q2
$268K Buy
3,716
+3,505
+1,661% +$253K ﹤0.01% 3541
2016
Q1
$17K Buy
211
+103
+95% +$8.3K ﹤0.01% 4855
2015
Q4
$8K Sell
108
-63
-37% -$4.67K ﹤0.01% 5270
2015
Q3
$66K Buy
171
+146
+584% +$56.4K ﹤0.01% 4419
2015
Q2
$10K Buy
+25
New +$10K ﹤0.01% 5548
2015
Q1
Sell
-3
Closed -$1K 5727
2014
Q4
$1K Buy
+3
New +$1K ﹤0.01% 5447